Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lucid Diagnostics Inc
(NQ:
LUCD
)
0.8398
-0.0002 (-0.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lucid Diagnostics Inc
< Previous
1
2
3
Next >
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer
November 09, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
November 02, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
Via
Benzinga
Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
August 15, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
August 11, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
August 04, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022
August 01, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements
August 02, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 05, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million.
Via
Benzinga
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
July 18, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
May 11, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
May 13, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
April 25, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
May 09, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
How Is The Market Feeling About Lucid Diagnostics Inc. - Common Stock?
March 30, 2022
Lucid Diagnostics Inc. - Common Stock's (NASDAQ:LUCD) short percent of float has fallen 4.35% since its last report. The company recently reported that it has 378.70 thousand...
Via
Benzinga
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
April 04, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
10 Biggest Price Target Changes For Tuesday
March 29, 2022
BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.
Via
Benzinga
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 28, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
March 30, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...
Via
Benzinga
PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
March 24, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
March 23, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
From
PAVmed Inc.
Via
Business Wire
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
February 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
February 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 02, 2022
Gainers Syros Pharmaceuticals (NASDAQ:SYRS
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 19, 2022
Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 19, 2022
Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.